UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 27, 2022 9:00 A.M.

Form:	S-3
CIK: 0001544227 Company Name: Tempest Therapeutics, Inc. File Number: 333-264989